Tag: biosimilars vs generics
Dec 16, 2025
Lot-to-Lot Variability in Biologics and Biosimilars: Why It Matters for Patients and Doctors
0 Comments
Lot-to-lot variability is natural in biologics and biosimilars due to their complex production using living cells. Unlike generics, biosimilars aren't identical copies but must match the reference product's variation range. Learn how regulators, labs, and patients manage this reality.
Read More